Eight markers (FGF2, IL17B, IP10, MIG, MIP1d, LOX1, OPN and SDC1) found to be upregulated in primary tumours were present in higher concentration in plasma of breast cancer patients. This evidence concerns the gene IL17B and neoplasm.